SKI Market

Indian Indices

Sensex

83,739.13 2,072.67
( 2.54%)

Global Indices

Nasdaq

49,433.27 519.79
(1.06%)

Dow Jones

6,997.90 37.87
(0.54%)

Hang Seng

54,706.11 2,050.93
(3.90%)

Nikkei 225

10,302.23 -39.33
(-0.38%)

Forex

USD-INR

91.61 -0.04
(-0.05%)

EUR-INR

108.55 -0.05
(-0.05%)

GBP-INR

125.35 -0.06
(-0.05%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.93

34821.43

EPS(TTM)

Face Value()

Div & Yield %

75.48

1.01

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	343.98	288.60	315.12	275.98	209.05	180.67
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	343.98	288.60	315.12	275.98	209.05	180.67
Other Income	4.83	3.71	3.47	1.45	0.81	3.02
Stock Adjustments	0.00	-0.10	-0.11	-0.27	-2.98	-0.36
Total Income	348.81	292.21	318.48	277.16	206.88	183.33
EXPENDITURE :
Raw Materials	43.47	34.55	42.15	40.96	35.25	32.41
Power & Fuel Cost	12.67	12.32	14.39	11.31	10.24	10.78
Employee Cost	91.28	85.19	85.62	70.85	57.28	57.59
Other Manufacturing Expenses	30.50	25.09	30.93	38.37	22.98	20.90
Selling & Administrative Expenses	39.05	32.08	42.65	28.03	21.24	26.44
Miscellaneous Expenses	5.06	13.02	5.72	7.65	6.39	2.17
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	222.04	202.26	221.46	197.16	153.38	150.30
Operating Profit	126.78	89.95	97.01	80.01	53.50	33.04
Interest	1.90	2.10	2.64	1.50	2.17	3.77
Gross Profit	124.88	87.85	94.37	78.51	51.33	29.27
Depreciation	35.29	33.14	30.54	23.16	22.94	20.92
Profit Before Tax	89.59	54.71	63.83	55.35	28.39	8.35
Tax	20.98	16.87	18.77	15.32	7.63	2.97
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.27	-3.18	-2.24	-1.03	-0.49	-1.55
Reported Net Profit	67.34	41.01	47.30	41.06	21.26	6.93
Extraordinary Items	0.02	0.40	0.17	-0.90	-0.01	0.10
Adjusted Net Profit	67.32	40.61	47.13	41.96	21.27	6.83
Adjustment below Net Profit	0.00	-2.73	0.00	0.00	0.00	-0.91
P & L Balance brought forward	217.25	183.41	142.17	105.53	84.27	82.67
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	4.43	4.43	4.42	4.42	0.00	4.42
P & L Balance carried down	280.16	217.25	185.04	142.17	105.53	84.27
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	100.00	100.00	100.00	100.00	100.00	0.00
Dividend Per Share(Rs)	2.00	2.00	2.00	2.00	2.00	0.00
Earnings Per Share-Unit Curr	30.29	18.50	21.37	18.57	9.62	3.13
Earnings Per Share(Adj)-Unit Curr	15.15	9.25	10.69	9.29	4.81	1.57
Book Value-Unit Curr	170.38	141.69	126.79	105.68	87.89	78.23
Book Value(Adj)-Unit Curr	85.19	70.85	63.40	52.84	43.95	39.12

83,739.13 2,072.67 ( 2.54%)

49,433.27 519.79 (1.06%)

6,997.90 37.87 (0.54%)

54,706.11 2,050.93 (3.90%)

10,302.23 -39.33 (-0.38%)

91.61 -0.04 (-0.05%)

108.55 -0.05 (-0.05%)

125.35 -0.06 (-0.05%)

0.59 0.00 (-0.07%)